You are here

  • Home
  • Archive
  • Volume 4, Issue 2
  • Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial

Citation Tools

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Nordberg LB, Lillegraven S, Aga A, et al
Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial
RMD Open 2018;4:e000752. doi: 10.1136/rmdopen-2018-000752